About Neha

Neha represents emerging and high-growth companies through all stages of the corporate life cycle. She advises clients on various corporate transactions, including private financings, public offerings and mergers & acquisitions. She also provides day-to-day corporate governance counsel to public and private companies.

View full bio

Experience

Enavate Sciences Co-Leads Sudo Biosciences’ $116 Million Series B

Enavate Sciences Co-Leads Sudo Biosciences’ $116 Million Series B

December 20, 2023

Cooley advised Enavate Sciences, a top investment firm, as the co-lead investor in the $116 million Series B financing round of Sudo Biosciences, a biopharmaceutical company committed to designing and developing best-in-class precision tyrosine kinase 2 inhibitors. Partners Marc Recht and Brandon Fenn led the Cooley team advising Enavate Sciences.

Related contacts

Marc Recht
Partner, Boston
Brandon W. Fenn
Partner, New York
Alex Abelson
Associate, New York
Neha Mehta
Associate, New York

Related Practices & Industries

Emerging Companies
Venture Capital
Life Sciences

Admissions and credentials

New York

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.